Ataluren: A Novel Targeted Therapeutic Approach for the Treatment of Cystic Fibrosis
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 2
Abstract
A lethal autosomal recessive genetic disease, cystic fibrosis (CF) is most common in Caucasians and the prevalence varies with the ethnic origin of the population. Patients with CF lack adequate levels of the CF transmembrane conductance receptor (CFTR) protein, a chloride channel necessary for normal function of the lung, pancreas, liver and other organs. Nonsense (premature stop codon) mutations in mRNA for the CFTR cause CF in approximately 10% of patients. Ataluren, a protein restoration therapy, is designed to promote the translational read-through of premature stop codons that helps to overcome the nonsense mutation and enable the production of a full-length, functional CFTR protein. Insertion of a near cognate amino acid at a premature stop codon allows the protein translation to continue until one of the several stop codons normally present at the ends of mRNA transcript is reached and properly utilized. It is a “corrector” drug specific for type I mutation defects. Ataluren is a novel, orally bioavailable drug that addresses the molecular basis of the disease. Phase III Clinical trials have shown it to be efficacious and well tolerated. It represents a breakthrough in the pharmacological advances for a rare genetic disease.
Authors and Affiliations
Suruchi Aditya*| Asstt. Prof, Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh, India, Surya Kant Mathur| Professor, Department of Pediatrics, MM Institute of Medical Sciences, Mullana, Ambala, India
Keywords
Related Articles
- EP ID EP1649
- DOI -
- Views 438
- Downloads 24
Delayed Release Pharmaceutical Pellets having Duloxetine Hydrochloride Containing Core and Acid Resistant Acrylic Polymer Based Outer Layer Coat.
The aim of this investigation was to develop a delayed release pellets dosage form of duloxetine hydrochloride. Drug loaded nuclei was prepared using powder-layering technique in a conventional coating pan. The nuclei wa...
CISPLATIN – A CHOICE OF DRUG FOR METASTATIC NON-SEMINOMATOUS GERM CELL CARCINOMA
Cisplatin is a type of Medical Treatment Called Chemotherapy. The Purpose of Chemotherapy to Kill Cancer Cell or Prevent the growth. Cancer starts when the cells of an organ or tissue in the body become abnormal. They gr...
MULTIDRUG LOADED GASTRORETENTIVE FILMS FOR THE TRATMENT OF H. PYLORI INFECTION
The objective of the present work was to develop innovative gastro retentive formulation based on mucoadhesive patch systems using the solvent casting technique, allowing a final structure with improved cohesion by mucoa...
A Validated HPLC Method for the Determination of Rabeprazole in Bulk and Pharmaceutical Dosage form.
A reversed-phase high performance liquid chromatography (RP-HPLC) method was developed and validated for the estimation of Rabeprazole in bulk and tablets dosage forms. The separation was achieved on C18 analytical colum...
PROGRESSING DIRECTED THERAPIES USING MOLECULAR IMAGING
The clinical studies that are using fluorine-18 tracers succumb to four general sorts: treatment planning, either for pharmaceutical therapy or radiation therapy; prescient or reaction marker studies for new pharmaceuti...